Clinical Trials Directory

Trials / Suspended

SuspendedNCT01557192

Low Field Magnetic Stimulation (LFMS) in Mood Disorders: 6 Treatments

Low Field Magnetic Stimulation in Mood Disorders in Six Visits

Status
Suspended
Phase
Phase 1
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Not accepted

Summary

To demonstrate the efficacy of multiple applications of Low Field Magnetic Stimulation (LFMS) as an antidepressant treatment in subjects with mood disorders.

Detailed description

The Low Field Magnetic Stimulation (LFMS) procedure is an application of a series of electromagnetic pulses to the brain lasting twenty minutes. The field and timing parameters of the LFMS pulses, such as pulse timing, duration, frequency, and electric and magnetic field distribution and direction are different from other neurostimulation methods. The mechanism of action for the antidepressant effects of LFMS is hypothesized to be an effect on dendritic or synaptic activity in the cortex, brought about by low level electrical stimulation applied with particular timing. This is analogous to the synaptic effects of pharmaceutical antidepressants in providing a "boost" to synapses in certain brain regions. Previous investigations of LFMS included depressed subjects with bipolar disorder. This study will evaluate the antidepressant effects of multiple LFMS treatments in bipolar disorder and major depressive disorder.

Conditions

Interventions

TypeNameDescription
DEVICELow Field Magnetic Stimulation DeviceThe Low Field Magnetic Stimulation (LFMS) procedure is an application of a series of electromagnetic pulses to the brain lasting twenty minutes. Subjects will be given one 20 minute exposure to either the LFMS or sham electromagnetic field treatment.

Timeline

Start date
2010-05-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2012-03-19
Last updated
2016-04-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01557192. Inclusion in this directory is not an endorsement.